ALB-dNLR Score Predicts Mortality in Coronary Artery Disease Patients After Percutaneous Coronary Intervention

Wen-Juan Xiu1, Hai-Tao Yang1, Ying-Ying Zheng1,2

  • 1Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.

Insights

The albumin/derived neutrophil and lymphocyte ratio (ALB-dNLR) score predicts mortality in patients with coronary artery disease (CAD) after percutaneous coronary intervention (PCI). Higher ALB-dNLR scores are associated with increased risks of all-cause and cardiac mortality post-PCI.

Area of Science:

  • Cardiology
  • Biomarkers
  • Inflammation Markers

Background:

  • The prognostic value of the albumin/derived neutrophil and lymphocyte ratio (ALB-dNLR) in patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) remains unclear.
  • Inflammatory markers are increasingly recognized for their role in cardiovascular disease outcomes.

Purpose of the Study:

  • To investigate the association between the ALB-dNLR score and patient outcomes following PCI.
  • To determine if ALB-dNLR can serve as a predictive biomarker for mortality in CAD patients post-PCI.

Main Methods:

  • A cohort of 6,050 patients undergoing PCI was analyzed.
  • Patients were stratified into three groups based on ALB-dNLR scores.
  • Cox proportional hazard models were used to assess the predictive value of ALB-dNLR for all-cause mortality (ACM) and cardiac mortality (CM).

Main Results:

  • Significant differences in ACM and CM rates were observed across ALB-dNLR score groups.
  • The ALB-dNLR score independently predicted both ACM and CM in multivariate analysis.
  • These predictive associations were also observed specifically in male patients.

Conclusions:

  • The ALB-dNLR score is a reliable predictor of mortality in patients with CAD after PCI.
  • Elevated ALB-dNLR scores indicate a higher risk of adverse outcomes, including death, post-PCI.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
35
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
142
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
47
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
64
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
243